课题基金 / 基金详情

Overcoming Host Restriction Factors to Develop Better Animal Models for HIV/AIDS

Overcoming Host Restriction Factors to Develop Better Animal Models for HIV/AIDS
克服宿主限制因素开发更好的艾滋病毒/艾滋病动物模型
批准号:
9383261
负责人:
Theodora Hatziioannou
金额:
$38.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-07-01 至 2018-06-30

项目摘要

项目成果

Theodora Hatziioannou的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): HIV-1, the predominant cause of AIDS in humans, is unable to replicate in most non-human species. Therefore, the most practical animal model of human AIDS consists of infection of rhesus macaques with SIVMAC or chimeras derived from SIVMAC. However, the usefulness of these models is limited by the fact that HIV-1 and SIVMAC are distinct viruses. Based on an understanding of species-specific restriction factors, we have generated recombinant viruses, named simian tropic HIV (stHIV), that are almost entirely derived from HIV-1 but can replicate in pigtailed macaques. During the last funding cycle we have used animal adaptation to develop stHIV isolates that cause AIDS in pigtail macaques. Additionally, we have studied the effects of known restriction factors on stHIV replication and unveiled the activity of novel, as yet unidentified, inhibitors that are induced by IFNα and limit lentiviral replication in a species-specific manner in primary cells. The aims of this proposal are to further develop stHIV by generating infectious molecular clones that are consistently pathogenic following mucosal challenges in both pigtail and rhesus macaques and are based on HIV-1 strains circulating in humans. To achieve these aims our studies will include a more detailed characterization of restriction factor polymorphism and activity in macaques and how these drive virus evolution in animals. Additionally, we will identify novel IFNα-induced inhibitors that limit stHIV replication in macaque cells and generate stHIV variants that can overcome them. Our preliminary data suggest that these goals are feasible and will lead to the successful development of stHIV, an advance that has the potential to transform non- human primate models for HIV-1 drug and vaccine development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
  • 批准号:
    10327990
  • 项目类别:
  • 资助金额:
    $55.21万
  • 财政年份:
    2022
  • 负责人:
    Theodora Hatziioannou
  • 依托单位:
Administrative Core
  • 批准号:
    10841238
  • 项目类别:
  • 资助金额:
    $33.82万
  • 财政年份:
    2022
  • 负责人:
    Theodora Hatziioannou
  • 依托单位:
Generation and in vitro/vivo evaluation of an R5-tropic SHIV library
  • 批准号:
    8210491
  • 项目类别:
  • 资助金额:
    $27.3万
  • 财政年份:
    2011
  • 负责人:
    Theodora Hatziioannou
  • 依托单位:
Generation and in vitro/vivo evaluation of an R5-tropic SHIV library
  • 批准号:
    8305464
  • 项目类别:
  • 资助金额:
    $22.75万
  • 财政年份:
    2011
  • 负责人:
    Theodora Hatziioannou
  • 依托单位:
国内基金
海外基金
lncRNA-HOST2—USP15—VGLL4轴促进乳腺癌肝转移的机制研究
  • 批准号:
    82073204
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2020
  • 负责人:
    房林
  • 依托单位:
新鉴定PA-X“host-shutoff”功能区调控H7N9禽流感病毒毒力的机制
  • 批准号:
    32072832
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    胡娇
  • 依托单位:
能量代谢触发植入干细胞和损伤视网膜细胞Graft-to Host细胞间通讯/物质交换及命运转变的机制
Intronic miR-944联合Host gene p63在肺鳞癌中的作用机制及其诊断价值研究
  • 批准号:
    81572275
  • 项目类别:
    面上项目
  • 资助金额:
    65.0万元
  • 批准年份:
    2015
  • 负责人:
    邢凌霄
  • 依托单位: